China SXT Pharmaceuticals, Inc.
SXTC · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $12 | $17 | $16 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2 | $1 | $1 | $6 |
| Inventory | $1 | $1 | $1 | $1 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $21 | $14 | $20 | $22 |
| Property Plant & Equip (Net) | $0 | $1 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $8 | $9 | $9 |
| Total NC Assets | $0 | $9 | $10 | $11 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $22 | $23 | $30 | $34 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $1 | $2 | $3 | $2 |
| Tax Payable | $1 | $1 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $4 | $8 | $12 |
| Total Curr. Liab. | $6 | $9 | $14 | $17 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | -$4 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6 | $9 | $15 | $17 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $45 | $4 | $1 | $0 |
| Retained Earnings | -$28 | -$25 | -$22 | -$16 |
| AOCI | -$1 | -$1 | -$0 | $1 |
| Other Equity | $0 | $35 | $36 | $31 |
| Total Equity | $15 | $14 | $15 | $16 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $22 | $23 | $30 | $34 |
| Net Debt | -$17 | -$9 | -$14 | -$13 |